trending Market Intelligence /marketintelligence/en/news-insights/trending/zj9lmwrqvgow6qjdfctfdw2 content esgSubNav
In This List

Atara Biotherapeutics starts $150M common stock offering

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Atara Biotherapeutics starts $150M common stock offering

Atara Biotherapeutics Inc. is selling $150 million of its common shares in an underwritten public offering.

The company also expects to grant the underwriters an option to buy up to an additional $22.5 million of common shares.

J.P. Morgan and Cowen are acting as joint book-running managers for the proposed offering.